KalVista Pharmaceuticals, Inc. — SC 13G/A Filings
43 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by KalVista Pharmaceuticals, Inc. (KALV), sorted by most recent first. Each row links to the full filing on EdgarLookup. KalVista Pharmaceuticals, Inc. has filed 43 SC 13G/A documents with the SEC since 2005. To view all SEC filings by KalVista Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-KT
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
PRE 14A
PREM14A
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 3 | 0001214659-24-019108 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000919574-24-006727 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-001112 | Nov 12, 2024 | — |
| SC 13G/A | KALVISTA PHARMACEUTICALS, INC. | 0000902664-24-006397 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000506 | Nov 4, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024231 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002872 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000919574-24-001072 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001216 | Feb 9, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-130059 | Dec 28, 2023 | — |
| SC 13G/A | — | 0001172661-23-001384 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-23-002400 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001172661-23-000837 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-23-010893 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000919574-23-000971 | Feb 13, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000245 | Feb 6, 2023 | — |
| SC 13G/A | — | 0001306550-23-000113 | Jan 6, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-091309 | Aug 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-041897 | Feb 14, 2022 | — |
| SC 13G/A | KALVISTA PHARMACEUTICALS, INC. | 0001104659-22-022751 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001580642-22-000830 | Feb 14, 2022 | — |
| SC 13G/A | — | 0001172661-22-000421 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-22-007095 | Feb 11, 2022 | — |
| SC 13G/A | — | 0000919574-22-000919 | Feb 11, 2022 | — |
| SC 13G/A | — | 0001193805-22-000237 | Feb 11, 2022 | — |
| SC 13G/A | — | 0000834237-22-003856 | Feb 1, 2022 | — |
| SC 13G/A | — | 0000315066-21-001580 | Jun 10, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-043558 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-21-009010 | Feb 12, 2021 | — |
| SC 13G/A | — | 0000315066-21-001084 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000315066-20-001437 | Apr 10, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-021718 | Feb 14, 2020 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-20-003600 | Feb 13, 2020 | — |
| SC 13G/A | — | 0001193805-20-000199 | Feb 13, 2020 | — |
| SC 13G/A | SC 13G/A | 0001580642-20-000514 | Feb 4, 2020 | — |
| SC 13G/A | SC 13G/A | 0001580642-19-000781 | Feb 13, 2019 | — |
| SC 13G/A | SC 13G/A | 0001104659-18-056030 | Sep 10, 2018 | — |
| SC 13G/A | CBYL AS OF 08/31/2016 | 0000080255-16-001300 | Sep 12, 2016 | — |
| SC 13G/A | — | 0000315066-16-005828 | May 10, 2016 | — |
| SC 13G/A | — | 0000315066-16-005727 | Apr 11, 2016 | — |
| SC 13G/A | CBYL AS OF 12/31/2015 | 0000080255-16-001198 | Feb 12, 2016 | — |
| SC 13G/A | — | 0000315066-16-004962 | Feb 12, 2016 | — |
| SC 13G/A | — | 0000919574-16-010160 | Feb 12, 2016 | — |